Steven Gelone
2018
In 2018, Steven Gelone earned a total compensation of $1.3M as President and Chief Operating Officer at Nabriva Therapeutics AG, a 32% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $126,822 |
|---|---|
| Option Awards | $546,738 |
| Salary | $426,104 |
| Stock Awards | $225,255 |
| Other | $15,116 |
| Total | $1,340,035 |
Gelone received $546.7K in option awards, accounting for 41% of the total pay in 2018.
Gelone also received $126.8K in non-equity incentive plan, $426.1K in salary, $225.3K in stock awards and $15.1K in other compensation.
Rankings
In 2018, Steven Gelone's compensation ranked 7,721st out of 14,244 executives tracked by ExecPay. In other words, Gelone earned more than 45.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,721 out of 14,244 | 46th |
Division Manufacturing | 3,004 out of 5,759 | 48th |
Major group Chemicals And Allied Products | 1,125 out of 2,122 | 47th |
Industry group Drugs | 949 out of 1,811 | 48th |
Industry Pharmaceutical Preparations | 739 out of 1,385 | 47th |
Source: SEC filing on June 14, 2019.
Gelone's colleagues
We found three more compensation records of executives who worked with Steven Gelone at Nabriva Therapeutics AG in 2018.